allogeneic

Type: Keyphrase
Name: allogeneic
First reported 16 hours ago - Updated 16 hours ago - 1 reports

A CD8 T cell-IDO axis is required for mesenchymal stem cell suppression of human SLE

ABSTRACTObjective: Allogeneic mesenchymal stem cells (MSCs) exhibit therapeutic effects for human autoimmune diseases including systemic lupus erythematosus (SLE), but the underlying mechanisms remain largely unknown. The aim of this study is to investigate ... [Published Arthritis & Rheumatism - 16 hours ago]
First reported 16 hours ago - Updated 16 hours ago - 1 reports

President of Leading South Korean Biopharmaceutical Company Green Cross Holdings Joins Stemedica’s Board of Directors

Stemedica Cell Technologies Inc., a leading manufacturer of adult,allogeneic stem cells and stem cell factors, welcomes Byung-Geon “BG”Rhee, Ph.D., President of Green Cross Holdings, a South Koreanbiopharmaceutical company, to its board of directors. ... [Published 4 Traders - 16 hours ago]
First reported Apr 21 2014 - Updated Apr 22 2014 - 1 reports

One Year Later, I'm Back at The Boston Marathon Finish Line

One Year Later, I’m Back at The Boston Marathon Finish LineBy Published Apr 21, 2014YOUR REACTION?I have been waiting for this moment since 4:48 pm on April 15 th , 2013 – the moment when two policemen pulled me off the course at mile 25 of the Boston ... [Published EverydayHealth.com - Apr 21 2014]
First reported Apr 18 2014 - Updated Apr 18 2014 - 1 reports

New Findings on Stem Cells Discussed by Researchers at Brigham and Women's Hospital

(NewsRx) -- By a News Reporter-Staff News Editor at Stem Cell Week -- Current study results on Stem Cell Research have been published. According to news reporting originating from Boston, Massachusetts, by NewsRx correspondents, research stated, "The ... [Published NewsRX - Apr 18 2014]
First reported Apr 18 2014 - Updated Apr 18 2014 - 1 reports

Investigators at State University of New York Describe Findings in Multiple Myeloma

(NewsRx) -- By a News Reporter-Staff News Editor at Blood Weekly -- Current study results on Cardiovascular Diseases and Conditions have been published. According to news reporting originating from Stony Brook, New York, by NewsRx correspondents, research ... [Published NewsRX - Apr 18 2014]
First reported Apr 18 2014 - Updated Apr 18 2014 - 1 reports

Recent Findings in Anemia Described by Researchers from Jichi Medical University

(NewsRx) -- By a News Reporter-Staff News Editor at Blood Weekly -- Data detailed on Hematologic Diseases have been presented. According to news originating from Saitama, Japan, by NewsRx correspondents, research stated, "Conditioning regimens consisting ... [Published NewsRX - Apr 18 2014]
First reported Apr 18 2014 - Updated Apr 18 2014 - 1 reports

New Findings from INSERM in the Area of Bone Marrow Transplantation Reported

(NewsRx) -- By a News Reporter-Staff News Editor at Blood Weekly -- Investigators discuss new findings in Transplantation Research. According to news reporting out of Paris, France, by NewsRx editors, research stated, "Allogeneic hematopoietic SCT (HSCT) ... [Published NewsRX - Apr 18 2014]
First reported Apr 18 2014 - Updated Apr 18 2014 - 1 reports

Investigators from Shanghai Jiao-Tong University Target Stem Cells

(NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- New research on Stem Cell Research is the subject of a report. According to news reporting from Shanghai, People's Republic of China, by NewsRx journalists, research stated, "To ... [Published NewsRX - Apr 18 2014]
First reported Apr 17 2014 - Updated Apr 17 2014 - 1 reports

Ear Replantation

A 19-year-old woman presented with amputation of her left ear by a pit bull (Panels A and B). The patient's tetanus vaccination and the dog's rabies vaccination were up to date. The ear was débrided and replanted by microvascular anastomosis of a 0.3-mm ... [Published New England Journal of Medicine - Apr 17 2014]
First reported Apr 17 2014 - Updated Apr 17 2014 - 1 reports

Research from Yale University School of Medicine Yields New Findings on Endothelial Cells

By a News Reporter-Staff News Editor at Biotech Week -- Investigators publish new report on Endothelial Cells. According to news reporting originating in New Haven, Connecticut , by NewsRx journalists, research stated, "Human graft endothelial cells (ECs) ... [Published HispanicBusiness.com - Apr 17 2014]
First reported Apr 16 2014 - Updated Apr 16 2014 - 1 reports

Immunicum : Patent Application Titled "Method for Priming of T Cells" Published Online

By a News Reporter-Staff News Editor at AIDS Weekly -- According to news reporting originating from Washington, D.C. , by NewsRx journalists, a patent application by the inventors Karlsson-Parra, Alex (Uppsala, SE); Wallgren, Anna-Carin (Uppsala, SE); ... [Published 4 Traders - Apr 16 2014]
First reported Apr 16 2014 - Updated Apr 16 2014 - 1 reports

Reports Outline Gene Therapy Study Findings from University of Strasbourg

By a News Reporter-Staff News Editor at Cancer Gene Therapy Week -- A new study on Biotechnology is now available. According to news reporting out of Strasbourg, France , by NewsRx editors, research stated, "Cell therapy based on alloreactivity has completed ... [Published HispanicBusiness.com - Apr 16 2014]

Quotes

...many of whom may ultimately require HSC transplantation," commented Pratik Multani, M D , M S , Chief Medical Officer of Fate Therapeutics. "Building upon our encouraging clinical experience with PROHEMA ® in adult patients, we look forward to expanding our clinical program to pediatric patients with life-threatening forms of leukemia and other hematologic malignancies. Our goal is to deliver a pharmacologically-optimized HSC therapeutic that can support rapid and durable hematologic and immunologic reconstitution, and enable the curative potential of HSC transplantation in patients across a wide range of ages and a broad spectrum of life-threatening malignant and rare genetic disorders."
Dr. Kinneret Savitsky , Chief Executive Officer of BioLineRx , said, "We are extremely pleased that our promising and versatile therapeutic candidate is ready to commence a Phase 1/2 clinical trial for a third indication, namely CML. Prof. Nagler's decision to pursue BL-8040 for CML in an independent clinical study is a testament to the potential he sees in our molecule for treating hematologic cancers. Each of these indications stands to benefit from the two main characteristics of BL-8040 - its ability to mobilize cells from the bone marrow into the peripheral blood system, and its ability to induce cancer cellcell death directly."
...According to news reporting originating from Boston, Massachusetts, by NewsRx correspondents, research stated, "The long-term impact of allogeneic hematopoietic stem cell transplantation (HSCT) on human immunodeficiency virus type 1 (HIV-1) reservoirs in patients receiving combination antiretroviral therapy (cART) is largely unknown. We studied the effects of a reduced-intensity conditioning allogeneic HSCT from donors with wild-type-CCR5(+) cells on HIV-1 peripheral blood reservoirs in 2 patients heterozygous for the ccr5'32... We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3."
...According to news reporting out of Paris, France, by NewsRx editors, research stated, "Allogeneic hematopoietic SCT (HSCT) appears to be an efficient tool to cure high-risk AML in first CR but the choice between BUbased or TBI-based conditioning regimens still remains controversial. In order to analyze the impact of conditioning regimen on long-term survival, we conducted a retrospective analysis from French registry data including all consecutive patients under 18 years old (n=226) from 1980 to 2004 transplanted for AML in CR1 from... We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3."

More Content

All (215) | News (189) | Reports (0) | Blogs (20) | Audio/Video (0) | Fact Sheets (0) | Press Releases (3)
sort by: Date | Relevance
Fate Therapeutics Announces FDA Clearance of IN... [Published Virtual Strategy Magazine - 35 mins ago]
Fate Therapeutics Announces FDA Clearance of IN... [Published Individual.com - 44 mins ago]
Fate Therapeutics Announces FDA Clearance of IN... [Published Benzinga.com - 52 mins ago]
BIOLINERX : Secures Approval for Investigator-I... [Published 4 Traders - 7 hours ago]
Progressive Outer Retinal Necrosis and Immunosu... [Published Sexual Development - 12 hours ago]
A CD8 T cell-IDO axis is required for mesenchym... [Published Arthritis & Rheumatism - 16 hours ago]
President of Leading South Korean Biopharmaceut... [Published 4 Traders - 16 hours ago]
Narayana Health City performs 300 bone marrow t... [Published PharmaBiz - Apr 22 2014]
NARAYANA HEALTH CITY SHOWCASES EFFICACY OF BONE... [Published This Week Bangalore - Apr 22 2014]
X-linked adrenoleukodystrophy: very long-chain ... [Published Bionity.com - Apr 22 2014]
Tissue engineering methods and compositions [Published PharmCast - Apr 22 2014]
U.S. Cardiologists Indicate Ivabradine May Beco... [Published Diagnostic & Invasive Cardiology - Apr 22 2014]
One Year Later, I'm Back at The Boston Marathon... [Published EverydayHealth.com - Apr 21 2014]
Irving Bone Marrow Transplant Unit Opens at New... [Published PRWeb - Apr 18 2014]
New Findings on Stem Cells Discussed by Researc... [Published NewsRX - Apr 18 2014]
Advanced Biologics publishes OsteoAMP(R) cervic... [Published NewsRX - Apr 18 2014]
New Findings from INSERM in the Area of Bone Ma... [Published NewsRX - Apr 18 2014]
Recent Findings in Anemia Described by Research... [Published NewsRX - Apr 18 2014]
Investigators at State University of New York D... [Published NewsRX - Apr 18 2014]
Investigators from Shanghai Jiao-Tong Universit... [Published NewsRX - Apr 18 2014]
IL-3 and CSF-1 Interact to Promote Generation o... [Published PLoS medicine - Apr 17 2014]
Legal Settlement for Astellas Pharma - Analyst ... [Published Nasdaq - Apr 17 2014]
Kamada and Baxter initiate Phase I/II graft-ver... [Published Individual.com - Apr 17 2014]
Legal Settlement for Astellas Pharma [Published Zacks.com - Apr 17 2014]
Ear Replantation [Published New England Journal of Medicine - Apr 17 2014]
Exercise in Patients With Non-Small Cell Lung C... [Published General Medicine eJournal - Apr 17 2014]
Advances in Celiac Disease [Published Diabetes Care - Apr 17 2014]
Methods and compositions for in vitro and in vi... [Published PharmCast - Apr 17 2014]
Recent Findings in Chronic Lymphocytic Leukemia... [Published HispanicBusiness.com - Apr 17 2014]
Research Conducted by I.H. Bartelink and Co-Aut... [Published HispanicBusiness.com - Apr 17 2014]
1 2 3 4 5 6 7 8
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
A Decellularized Oesophagus Demonstrated in Rats [Published Fight Aging! - Apr 16 2014]
Researchers here make use of the process of decellularization to match a donor organ to the recipient. In the ideal procedure, donor cells are removed and the remaining extracellular matrix of the organ is repopulated with the recipient's cells, ...
Heat Biologics, Inc. Presents Proprietary Allog... [Published Marketwire - Breaking News Releases - Apr 09 2014]
CHAPEL HILL, NC--(Marketwired - Apr 9, 2014) - Heat Biologics, Inc. ("Heat Biologics", "Heat" or the "Company")  (NASDAQ: HTBX), a clinical stage biopharmaceutical company focused on the development of novel cancer immunotherapies, announced today ...
FDA Grants IND Approval for Phase IIa Clinical ... [Published Business Wire Health News - Apr 02 2014]
SAN DIEGO--(BUSINESS WIRE)--CardioCell LLC has just received the FDA’s investigational new drug (IND) approval for a United States-based, Phase IIa clinical study using its allogeneic stem-cell therapy to treat subjects with chronic heart failure (CHF), ...
Orphan designation: Allogeneic bone-marrow-deri... [Published Orphan designations - Mar 24 2014]
Orphan designation: Autologous dendritic cells ... [Published Orphan designations - Mar 24 2014]
1 2 3 4

Press Releases

sort by: Date | Relevance
Immunicum’s abstract with data from a kidney ca... [Published GlobeNewswire: Acquisitions News - Mar 27 2014]
Immunicum reports promising preclinical results... [Published GlobeNewswire: Advertising News - Mar 06 2014]
POSITIVE SPINAL DISC REPAIR TRIAL RESULTS USING... [Published GlobeNewswire: Advertising News - Jan 29 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.